Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 22 February, 2019

Marinomed Biotech Ag

EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

PR Newswire/euro adhoc/

EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation
notification according to art. 135 para. 2 Stock Exchange Act

--------------------------------------------------------------------------------
  Notification of voting rights transmitted by euro adhoc with the aim of a
  Europe-wide distribution. The issuer is responsible for the content of this
  announcement.
--------------------------------------------------------------------------------


      Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018
                                                                 Wien, 22.2.2019
Overview

1. Issuer: Marinomed Biotech AG
2. Reason for the notification: Event changing the breakdown of voting rights
Other
3. Person subject to notification obligation
Acting in concert (Sec. 133 No. 7 BörseG 2018)
 ____________________________________________________________________________

|___First_name____|____Name/Surname_____|________City_________|___Country____
|Mohammed_________|Al_Sheikh____________|_____________________|______________
|Abdulmohsen______|Al_Sheikh____________|_____________________|______________|                 |Acropora Beteiligungs|Wien                 |Österreich   
|_________________|GmbH_________________|_____________________|______________
4. Name of shareholder(s):
5. Date on which the threshold was crossed or reached: 20.2.2019
6. Total positions
 ______________________________________________________________________________
|               |               |  % of voting  |              |              
|               |  % of voting  |rights through |Total of both |Total number 
of|               |rights attached|financial/other| in % (7.A +  | voting rights
|               |to shares (7.A)| instruments   |     7.B)     |   of issuer  

|_______________|_______________|(7.B.1_+_7.B.2)|______________|_______________|   Resulting   |               |               |              |              
| situation on  |               |               |              |              
|  the date on  |    23,27 %    |    0,00 %     |   23,27 %    |   1 430 772  
|which threshold|               |               |              |              
| was crossed / |               |               |              |              

|____reached____|_______________|_______________|______________|_______________|  Position of  |               |               |              |              
|   previous    |    26,42 %    |               |              |              
| notification  |               |               |              |              
|(if_applicable)|_______________|_______________|______________|_______________

Details
7. Notified details of the resulting situation:
 ______________________________________________________________________________

|A:_Voting_rights_attached_to_shares___________________________________________|             
|____Number_of_voting_rights____|_______%_of_voting_rights_______|             |    Direct     |   Indirect    |    Direct     |    Indirect   
|  ISIN Code  |(Sec 130 BörseG|(Sec 133 BörseG|(Sec 130 BörseG|(Sec 133 
BörseG

|_____________|_____2018)_____|_____2018)_____|_____2018)_____|_____2018)______
|ATMARINOMED6_|________332_910|_______________|________23,27_%|________________|_SUBTOTAL_A__|____________332_910____________|____________23,27_%_____________
 ______________________________________________________________________________
|B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 
|

|2018__________________________________________________________________________|             |               |               |Number of voting |             
|             |               |               | rights that may |             
|   Type of   |               |               |       be        | % of voting 
| instrument  |Expiration Date|Exercise Period|acquired if the  |    rights   
|             |               |               |  instrument is  |             

|_____________|_______________|_______________|____exercised____|______________|_____________|_______________|_SUBTOTAL_B.1__|_________________|______________
 _____________________________________________________________________________
|B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG

|2018_________________________________________________________________________|  Type of  | Expiration | Exercise  | Physical /  | Number of   |% of voting
|instrument |    Date    |  Period   |    Cash     |voting rights|   rights  

|___________|____________|___________|_Settlement__|_____________|____________|___________|____________|___________|SUBTOTAL_B.2_|_____________|____________

8. Information in relation to the person subject to the notification obligation:
Full chain of controlled undertakings through which the voting rights and/or the
financial/other instruments are effectively held starting with the ultimate
controlling natural person or legal entity:
 _____________________________________________________________________________
|          |            |           |             | Financial/  |            
|          |            | Directly  | Shares held |    other    |Total of 
both|   No.    |    Name    |controlled |directly (%) | instruments |     (%)    
|          |            |  by No.   |             |held directly|            

|__________|____________|___________|_____________|_____(%)_____|_____________|    1     |Abdulmohsen |           |             |             |            

|__________|Al_Sheikh___|___________|_____________|_____________|_____________|    2     |Mohammed Al |           |             |             |            

|__________|Sheikh______|___________|_____________|_____________|_____________|          |Acropora    |           |             |             |            
|    3     |Beteiligungs|    1,2    |      23,27 %|             |      23,27 
%|__________|GmbH________|___________|_____________|_____________|_____________
9. In case of proxy voting
Date of general meeting: -
Voting rights after general meeting: - is equivalent to - voting rights.
10. Sonstige Kommentare:
Die Beteiligungsmeldung erfolgt aufgrund der Schwellenunterschreitung wegen der
Kapitalerhöhung (Wandlung von ISIN AT00A1WD52)
Wien am 22.2.2019



end of announcement                         euro adhoc
--------------------------------------------------------------------------------



issuer:       Marinomed Biotech AG
              Veterinärplatz 1
              A-1210 Wien
phone:        0043250774460
FAX:          0043250774493
mail:         [email protected]
WWW:          www.marinomed.com
ISIN:         ATMARINOMED6, AT0000A1WD52
indexes:      
stockmarkets: Wien
language:     English
                
The content and accuracy of news releases published on this site and/or 
distributed by PR Newswire or its partners are the sole responsibility of the 
originating company or organisation. Whilst every effort is made to ensure the 
accuracy of our services, such releases are not actively monitored or reviewed 
by PR Newswire or its partners and under no circumstances shall PR Newswire or 
its partners be liable for any loss or damage resulting from the use of such 
information. All information should be checked prior to publication.

a d v e r t i s e m e n t